161 related articles for article (PubMed ID: 38184453)
21. [Use of PET/CT for staging of Ewing's sarcoma. Report of one case].
Barahona Z D; Adlerstein L I; Faure R MI
Rev Med Chil; 2020 Oct; 148(10):1504-1507. PubMed ID: 33844722
[TBL] [Abstract][Full Text] [Related]
22. Staging and follow-up of a Ewing sarcoma patient using
Garcia JR; Castañeda A; Morales La Madrid A; Bassa P; Soler M; Riera E
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(6):387-389. PubMed ID: 29107752
[No Abstract] [Full Text] [Related]
23. Functional image in soft tissue sarcomas: An update of the indications of
Rodríguez-Alfonso B; Simó-Perdigó M; Orcajo Rincón J
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(4):233-243. PubMed ID: 32616457
[TBL] [Abstract][Full Text] [Related]
24. PET/CT Variants and Pitfalls in Bone and Soft Tissue Sarcoma.
Benz MR; Crompton JG; Harder D
Semin Nucl Med; 2021 Nov; 51(6):584-592. PubMed ID: 34238508
[TBL] [Abstract][Full Text] [Related]
25. PET-CT staging affects time to treatment in sarcoma.
Lee L; Kazmer A; Colman MW; Gitelis S; Batus M; Blank AT
Surg Oncol; 2022 May; 41():101732. PubMed ID: 35235893
[TBL] [Abstract][Full Text] [Related]
26. Staging of newly diagnosed Ewing sarcoma: Results of bone marrow aspiration and biopsy versus (18)FDG-PET/CT imaging for bone marrow involvement.
Guinot A; Tabone-Eglinger S; Isnardi V; Bahri H; Surdez D; Delattre O; Pierron G; Villemeur M; Lapouble E; Brahmi M; Bouhamama A; Corradini N; Marec-Bérard P
Eur J Cancer; 2023 Jan; 179():56-64. PubMed ID: 36502618
[TBL] [Abstract][Full Text] [Related]
27. FDG PET/MR in initial staging of sarcoma: Initial experience and comparison with conventional imaging.
Platzek I; Beuthien-Baumann B; Schramm G; Maus J; Laniado M; Kotzerke J; van den Hoff J; Schuler M
Clin Imaging; 2017; 42():126-132. PubMed ID: 27951459
[TBL] [Abstract][Full Text] [Related]
28. [PET Research in Clinical Oncology].
Mitsumoto T; Takabatake M; Inoue K; Fukushi M
Igaku Butsuri; 2022; 42(2):80-87. PubMed ID: 35768265
[TBL] [Abstract][Full Text] [Related]
29. Clinical applications of positron emission tomography in sarcoma management.
Quak E; van de Luijtgaarden AC; de Geus-Oei LF; van der Graaf WT; Oyen WJ
Expert Rev Anticancer Ther; 2011 Feb; 11(2):195-204. PubMed ID: 21342039
[TBL] [Abstract][Full Text] [Related]
30. Estimated cumulative radiation dose received by diagnostic imaging during staging and treatment of operable Ewing sarcoma 2005-2012.
Johnsen B; Fasmer KE; Boye K; Rosendahl K; Trovik C; Biermann M; Aukland SM
Pediatr Radiol; 2017 Jan; 47(1):82-88. PubMed ID: 27815616
[TBL] [Abstract][Full Text] [Related]
31. Positron Emission Tomography/Computed Tomography Transformation of Oncology: Melanoma and Skin Malignancies.
Lee ST; Kovaleva N; Senko C; Kee D; Scott AM
PET Clin; 2024 Apr; 19(2):231-248. PubMed ID: 38233284
[TBL] [Abstract][Full Text] [Related]
32. [Positron emission tomography-computed tomography in tumors of the locomotor apparatus].
Gámez Cenzano C; Sabaté Llobera A; Narváez García JA; Rodríguez Bel L; García del Muro FJ
Radiologia; 2012 Sep; 54 Suppl 1():3-13. PubMed ID: 22959330
[TBL] [Abstract][Full Text] [Related]
33. FDG PET/CT imaging in primary osseous and soft tissue sarcomas: a retrospective review of 212 cases.
Charest M; Hickeson M; Lisbona R; Novales-Diaz JA; Derbekyan V; Turcotte RE
Eur J Nucl Med Mol Imaging; 2009 Dec; 36(12):1944-51. PubMed ID: 19593561
[TBL] [Abstract][Full Text] [Related]
34. F-18-FDG PET-CT in children and young adults with Ewing sarcoma diagnosed in Norway during 2005-2012: a national population-based study.
Johnsen B; Boye K; Rosendahl K; Biermann M; Trovik C; Aukland SM
Clin Physiol Funct Imaging; 2016 Nov; 36(6):441-446. PubMed ID: 26039107
[TBL] [Abstract][Full Text] [Related]
35. Meta-Analysis of the Diagnostic Accuracy of Primary Bone and Soft Tissue Sarcomas by 18F-FDG-PET.
Younis MH; Abu-Hijleh HA; Aldahamsheh OO; Abualruz A; Thalib L
Med Princ Pract; 2020; 29(5):465-472. PubMed ID: 31887730
[TBL] [Abstract][Full Text] [Related]
36. Fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung, and lymph node metastases in rhabdomyosarcoma.
Vaarwerk B; Breunis WB; Haveman LM; de Keizer B; Jehanno N; Borgwardt L; van Rijn RR; van den Berg H; Cohen JF; van Dalen EC; Merks JH
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012325. PubMed ID: 34753195
[TBL] [Abstract][Full Text] [Related]
37. Role of positron emission tomography/computed tomography in bone malignancies.
Peller PJ
Radiol Clin North Am; 2013 Sep; 51(5):845-64. PubMed ID: 24010909
[TBL] [Abstract][Full Text] [Related]
38. Fibroblast Activation Protein Inhibitor (FAPI)-PET Imaging in Sarcoma.
Kessler L
PET Clin; 2023 Jul; 18(3):353-359. PubMed ID: 37117120
[TBL] [Abstract][Full Text] [Related]
39. Pediatric FDG PET/CT: Physiologic uptake, normal variants, and benign conditions [corrected].
Bestic JM; Peterson JJ; Bancroft LW
Radiographics; 2009; 29(5):1487-500. PubMed ID: 19755607
[TBL] [Abstract][Full Text] [Related]
40. Necrosis on FDG PET/CT correlates with prognosis and mortality in sarcomas.
Rakheja R; Makis W; Tulbah R; Skamene S; Holcroft C; Nahal A; Turcotte R; Hickeson M
AJR Am J Roentgenol; 2013 Jul; 201(1):170-7. PubMed ID: 23789672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
